Bristol Myers Squibb (BMY)
$62.48 +1.78% Close Oct 30, 2026 Live
Bristol Myers Squibb stock today
Bristol Myers Squibb closed at $62.48 on October 30, 2026, up 1.78% on the day. Over the past year it returned +43.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $128 billion.
$50.00$60.00
NovJan 2026MarMayJulSep
| Period | BMY | S&P 500 (SPY) |
|---|---|---|
| 1 month | +1.2% | -0.9% |
| 3 months | -2.7% | +2.1% |
| Year to date | +21.0% | +11.7% |
| 1 year | +43.0% | +12.4% |
| 3 years | +40.4% | +88.5% |
| 5 years | +31.6% | +76.0% |
Key statistics
- Market value
- $128B
- P/E (trailing)
- 13.8
- Forward P/E
- 9.5
- Price / sales
- 2.6
- Dividend yield
- 4.03%
- 52-week range
- $45.59 to $68.09
About Bristol Myers Squibb
Develops and manufactures pharmaceutical products for oncology, immunology, cardiovascular, and cell therapy treatments.
Sector: Health Care · Industry: Pharmaceuticals
More on Bristol Myers Squibb
- Financials: revenue, earnings and segmentsRevenue -0% in the year to Dec 2025
- Valuation: P/E history and peersP/E 13.8, median 21.0 at its last 8 year ends
- Returns: what $1,000 became$1,000 ten years ago is $1,750 today
No forecast, no recommendation. This page describes Bristol Myers Squibb from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.